The Clorox Company (CLX) Fair Value & Analysis
Consumer Defensive · US · Market cap $11.9B · ISIN US1890541097
What is The Clorox Company really worth?
The Clorox Company
CLX · US
A solid business, currently priced close to our fair value of $100.40.
Strengths
Risks
For context
Fair value as of: Aug 30, 2026
From 25 valuation models · updated 6 days ago
Share price −9.9% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range ($60.79 to $143.82) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.
How to read this chart
60‑month range $86.12 – $159.79 · fair‑value band $60.79 – $143.82 · the $94.29 price screens below the $100.40 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 30, 2026.
Analysis
The Clorox Company (CLX) currently trades at $94.29, while our model-based Fair Value estimate is $100.40, implying the stock looks roughly 6.1% fairly valued today. The Quality Score stands at 74/100 (solid quality), in the Consumer Defensive sector. Bull case: the Growth Earnings group reads highest at a median of $111.08 per share, and 8 of the 25 models we run sit above the $94.29 price. Bear case: the Economic Profit group reads lowest at $18.38, and 17 of the 25 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, The Clorox Company generated revenue of $6.8B at a net margin of 11.2%. Revenue grew 0.1% year over year. It earns a return on equity of 54.6%. Net debt stands at $2.7B. Fundamentals as of Aug 30, 2026
Our scenario range runs from $60.79 (bear case) to $143.82 (bull case); at $94.29, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −36% fair-value upside, at 6%, CLX screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 12 months have passed since. In that time the company retained roughly $1.19 per share, which is 1.2 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 25 models by family
Widest divergence: Growth Earnings ($111.08) versus Asset-Based ($2.67). Highest evidence: FCF DCF (79).
Notify me when CLX reaches fair value
Put CLX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 70 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Full company description
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
The Clorox Company reported revenue of $7.1B in FY2025 versus $7.3B in FY2021, a compound −0.8%/yr. Reported net income was $810M in FY2025, compounding +3.3%/yr from FY2021.
of which total revenue +2.7 % · buybacks/dilution +0.7 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
Watch CLX: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Clorox (CLX) Down 9.3% Since Last Earnings Report: Can It Rebound?
- ADRNY or CLX: Which Is the Better Value Stock Right Now?
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 42/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| L'Oréal S.A LORL | C$24.76 | C$22.64 | −9% |
| Unilever PLC UNA | €55.92 | €40.47 | −28% |
| Colgate-Palmolive Company CL | $90.75 | $55.28 | −39% |
| 500696 500696 | ₹2,093 | ₹641.55 | −69% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | −61% |
| Kenvue Inc KVUE | $18.95 | $10.97 | −42% |
| Kimberly-Clark Corporation KMB | $109.55 | $79.71 | −27% |
| Henkel AG HEN3 | €75.82 | €85.95 | +13% |
| The Estée Lauder Companies Inc ESLA | €86.54 | €18.84 | −78% |
| Church & Dwight Co CHD | $101.26 | $65.12 | −36% |
Compare The Clorox Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is The Clorox Company (CLX) overvalued or undervalued?
What is the fair value of CLX?
What is the quality score of CLX?
What is the revenue of The Clorox Company (CLX)?
What is the net profit margin of CLX?
Does The Clorox Company pay a dividend?
Watch The Clorox Company in the live analysis
One click puts The Clorox Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.